Cinclus Pharma Holding AB
CINPHA | ST
Overview
Corporate Details
- ISIN(s):
- SE0020388577
- LEI:
- 549300TJBPSNZ3DO6B42
- Country:
- Sweden
- Address:
- Kungsbron 1, Plan 3, trappa G, 111 22 Stockholm
- Website:
- https://cincluspharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cinclus Pharma Holding AB is a Swedish biopharma company developing treatments for gastrointestinal diseases, with a focus on acid-related disorders.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 20:12 |
Declaration of Voting Results & Voting Rights Announcements
Beslut vid årsstämma i Cinclus Pharma Holding AB (publ) den 22 maj 2025
|
Swedish | 79.8 KB | |
| 2025-05-22 20:12 |
Declaration of Voting Results & Voting Rights Announcements
Resolutions at the Annual General Meeting in Cinclus Pharma Holding AB (publ) o…
|
English | 81.2 KB | |
| 2025-05-22 07:30 |
Regulatory News Service
Cinclus Pharma ingår partnerskap med Zentiva för att kommersialisera linaprazan…
|
Swedish | 93.4 KB | |
| 2025-05-22 07:30 |
Regulatory News Service
Cinclus Pharma Partners with Zentiva to Commercialize Linaprazan Glurate in Eur…
|
English | 92.2 KB | |
| 2025-05-20 08:00 |
Interim Report
|
Swedish | 2.5 MB | |
| 2025-05-20 08:00 |
Interim Report
|
English | 2.6 MB | |
| 2025-04-30 16:00 |
Annual Report (ESEF)
|
Swedish | 29.7 MB | |
| 2025-04-30 16:00 |
Annual Report (ESEF)
|
English | 29.7 MB | |
| 2025-02-20 08:00 |
Earnings Release
|
Swedish | 2.3 MB | |
| 2025-02-20 08:00 |
Annual Report
|
English | 2.3 MB | |
| 2025-01-03 17:00 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 8.1 KB | |
| 2024-12-30 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Cinclus Pharma
|
Swedish | 84.1 KB | |
| 2024-12-30 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Cinclus Pharma
|
English | 83.0 KB | |
| 2024-11-28 19:30 |
Transaction in Own Shares
Emission och återköp av C-aktier
|
Swedish | 76.8 KB | |
| 2024-11-28 19:30 |
Transaction in Own Shares
Issue and repurchase of class C shares
|
English | 76.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Immunic AG | United States of America | IMUX | |
| Incanthera plc | United Kingdom | N/A |